Showing results (361-370 of 734) with videos related to

Sort By:
Pageof 74
Leukemia & Lymphoma|February 5, 2015
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trialLuis Fayad, Stephen M Ansell, Ranjana Advani, et al.
Leukemia|February 27, 2014
TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphomaZ-Z Yang, D M Grote, B Xiu, et al.
British Journal of Rheumatology|February 1, 1986
Multicentre study of piroxicam versus naproxen in juvenile chronic arthritis, with special reference to problem areas in clinical trials of nonsteroidal anti-inflammatory drugs in childhoodP L Williams, B M Ansell, A Bell, et al.
British Journal of Haematology|May 18, 2006
Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, David J Inwards, et al.
Oncology|January 1, 1991
Sister chromatid exchanges in lymphocyte cultures of patients previously treated with dibromodulcitolS M Ansell, C E Jansen van Rensburg, B L Rapoport, et al.
Blood Advances|May 8, 2020
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignanciesStephen M Ansell, Ian Flinn, Matthew H Taylor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective studyLuis F Porrata, David J Inwards, Stephen M Ansell, et al.
Blood Cancer Journal|October 16, 2019
SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphomaYa-Ping Chen, Hyo Jin Kim, Hongyan Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patientsStephen M Ansell, Susan M Geyer, Matthew J Maurer, et al.
Blood|September 17, 2011
Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activitySherine F Elsawa, Anne J Novak, Steven C Ziesmer, et al.
Pageof 74